Belite Bio (BLTE) Stock: Buy, Sell, or Hold?
BLTE - Belite Bio, Inc American Depositary Shares
$159.56
-3.42 (-2.10%)
▼
5d:
-4.64%
30d:
-0.68%
90d:
+3.6%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When BLTE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$79.17
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$49.16
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLTE is currently trading at $159.56, which is considered slightly low relative to its 30-day fair value range of $158.81 to $178.47. From a valuation perspective, the stock is trading at a discount (Forward PE: 70.6) compared to its historical average (156.2). Remarkably, the market is currently pricing in an annual earnings decline of 23.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLTE is in a strong uptrend. The price is currently testing key support at $159.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $228.89 (+43.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLTE is in a strong uptrend. The price is currently testing key support at $159.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $228.89 (+43.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$158.81 -
$178.47
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.5% below Wall St target ($228.89)
- NEUTRAL: Bottoming setup forming (41/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$158.81 -
$178.47
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$159.00
Resistance Level
$178.44
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
70.60
Wall Street Target
$228.89
(+43.5%)
Valuation Discount vs History
-23.3% cheaper
PE vs Historical
70.6 vs 156.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-23.3%
(market-implied from PE analysis)
1-Year Target
$143.60
(-10%)
2-Year Target
$129.24
(-19%)
3-Year Target
$116.32
(-27%)
3-Yr Target (if PE normalizes)
(PE: 71→156)
$257.35
(+61%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 70.6 to 156.2
Stabilization Target:
$353.01
(+121.2%)
PE Expansion Potential:
+121.2%
Share & Embed Analysis
Last updated: October 03, 2026 7:02 PM ET
Data refreshes hourly during market hours. Next update: 8:02 PM
Data refreshes hourly during market hours. Next update: 8:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLTE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Nathan L Mata
SELL
1000 shares
2026-04-22
Nathan L Mata
SELL
1000 shares
2026-04-20
Nathan L Mata
SELL
1000 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
